KV11.1, NaV1.5, and CaV1.2 Transporter Proteins as Antitarget for Drug Cardiotoxicity

Int J Mol Sci. 2020 Oct 30;21(21):8099. doi: 10.3390/ijms21218099.

Abstract

Safety assessment of pharmaceuticals is a rapidly developing area of pharmacy and medicine. The new advanced guidelines for testing the toxicity of compounds require specialized tools that provide information on the tested drug in a quick and reliable way. Ion channels represent the third-largest target. As mentioned in the literature, ion channels are an indispensable part of the heart's work. In this paper the most important information concerning the guidelines for cardiotoxicity testing and the way the tests are conducted has been collected. Attention has been focused on the role of selected ion channels in this process.

Keywords: antitarget; drug cardiotoxicity; ion transporter proteins.

Publication types

  • Review

MeSH terms

  • Animals
  • Calcium Channels, L-Type / metabolism*
  • Cardiotoxicity / diagnosis*
  • Cardiotoxicity / etiology
  • Cardiotoxicity / metabolism
  • ERG1 Potassium Channel / metabolism*
  • Humans
  • NAV1.5 Voltage-Gated Sodium Channel / metabolism*
  • Pharmaceutical Preparations / administration & dosage*

Substances

  • Calcium Channels, L-Type
  • ERG1 Potassium Channel
  • L-type calcium channel alpha(1C)
  • NAV1.5 Voltage-Gated Sodium Channel
  • Pharmaceutical Preparations